Artiva Biotherapeutics
Latest round
- Series B
Last raised
- Feb 2021
Total raised
- $201M
Investors
- 16
About Artiva Biotherapeutics
Artiva Biotherapeutics, Inc.Founded in 2019 and headquartered in San Diego, US, Artiva Biotherapeutics, Inc. specializes in NK cell therapies.Artiva Biotherapeutics develops NK cell-based therapies, with its lead candidate, AlloNK®, designed to improve the efficacy of monoclonal antibodies in treating autoimmune diseases and cancers.41 mn, centered around the development and potential commercialization of its NK cell therapy products, especially AlloNK®.Following a successful IPO on July 18, 2024, where Artiva Biotherapeutics, Inc.04 mn by selling shares on the Nasdaq Global Select Market under the ticker symbol 'ARTV', the company plans to enhance its clinical development and operational infrastructure. The company continues to prioritize its lead product candidate, AlloNK®, with goals set for broader market penetration in 2024 and beyond.
Who invested in Artiva Biotherapeutics
16 investors across 2 rounds
See all investors in Artiva Biotherapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Artiva Biotherapeutics
Who invested in Artiva Biotherapeutics?
Artiva Biotherapeutics has 16 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Artiva Biotherapeutics raised?
Artiva Biotherapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Artiva Biotherapeutics last raise money?
Artiva Biotherapeutics's most recent round on record is a Series B, in Feb 2021.
What does Artiva Biotherapeutics do?
Artiva Biotherapeutics is a biotechnology company.
Where is Artiva Biotherapeutics headquartered?
Artiva Biotherapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Artiva Biotherapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Artiva Biotherapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Artiva Biotherapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.